```

[Federal Register Volume 87, Number 56 (Wednesday, March 23, 2022)]
[Notices]
[Pages 16496-16497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06159]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-985]

Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey Pharmaceutical Materials, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey Pharmaceutical Materials, Inc., has applied to 
be registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
May 23, 2022. Such persons may also file a written request for a 
hearing on the application on or before May 23, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not

[[Page 16497]]

instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on February 28, 2022, Johnson Matthey Pharmaceutical 
Materials, Inc., 2003 Nolte Drive, West Deptford, New Jersey 08066-
1742, applied to be registered as a bulk manufacturer of the following 
basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............    2010  I
Marihuana..............................    7360  I
Tetrahydrocannabinols..................    7370  I
Noroxymorphone.........................    9145  I
Difenoxin..............................    9168  I
Amphetamine............................    1100  II
Methamphetamine........................    1105  II
Lisdexamfetamine.......................    1205  II
Methylphenidate........................    1724  II
Nabilone...............................    7379  II
ANPP (4-Anilino-N-phenethyl-4-             8333  II
 piperidine).
Norfentanyl (N-phenyl-N-(piperidin-4-      8366  II
 yl) propionamide).
Cocaine................................    9041  II
Codeine................................    9050  II
Dihydrocodeine.........................    9120  II
Oxycodone..............................    9143  II
Hydromorphone..........................    9150  II
Diphenoxylate..........................    9170  II
Ecgonine...............................    9180  II
Hydrocodone............................    9193  II
Levorphanol............................    9220  II
Meperidine.............................    9230  II
Methadone..............................    9250  II
Methadone intermediate.................    9254  II
Morphine...............................    9300  II
Thebaine...............................    9333  II
Opium tincture.........................    9630  II
Oxymorphone............................    9652  II
Noroxymorphone.........................    9668  II
Alfentanil.............................    9737  II
Remifentanil...........................    9739  II
Sufentanil.............................    9740  II
Tapentadol.............................    9780  II
Fentanyl...............................    9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. In reference to drug codes 7360 (Marihuana), and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-06159 Filed 3-22-22; 8:45 am]
BILLING CODE P
```